Valuation (84%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 8.42 | N/A |
| PEG Ratio (TTM) | 4.12 | N/A |
| P/S Ratio (TTM) | 1.30 | N/A |
| P/B Ratio (TTM) | 0.75 | N/A |
| P/FCF Ratio (TTM) | 10.45 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.61 | N/A |
| Price to 5YR AVG FCF Ratio | 7.97 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.79% | N/A |
| ROE (TTM) | 9.31% | N/A |
| Net Profit Margin (TTM) | 15.75% | N/A |
| ROIC 5YR AVG | 16.77% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 2.46% | 38.42% | 40.47% |
| Revenue | 3.26% | 2.02% | 1,256.78% |
| Net Income | 1.43% | 35.70% | 36.98% |
| Cash Flow | 19.11% | 18.47% | 17.44% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.01 | N/A |
| Quick Ratio (TTM) | 1.01 | N/A |
| D/E Ratio (TTM) | 0.11 | N/A |
| Interest Coverage (TTM) | 1.41 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.33 | N/A |
| LTL to 5YR AVG FCF | 1.20 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.33% | N/A |